R&D
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Roquette & Thermo Fisher Enter Distribution Deal
For the Roquette portfolio of pharmaceutical ingredients in the United States and Canada12.18.18
-
Bio News | Clinical Trials | Industry News | R&D
Neurotrope Announces Publication of Phase 2 Alzheimer's Study
The multidose, exploratory trial was to evaluate Bryostatin-1 as a treatment of cognitive deficits in moderate to severe Alzheimer's disease12.17.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | Laboratory Testing | R&D
Alkermes, Biogen Submit NDA to FDA
For diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
KIO, Pfizer Enter Research Collaboration
To develop RIG-I agonist immunotherapies for the treatment of cancer12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Orchard & SIRION Enter License Agreement
SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™12.14.18
-
Bio News | Drug Development | Facilities | Industry News | Promotions & Moves | R&D
HemaCare Moves Into New HQ
Company has officially moved its global headquarters to Northridge, California, in a 40,000 sq. ft. building in the heart of the San Fernando ValleyVideos
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
-
Bio News | Collaborations & Alliances | Industry News | Laboratory Testing | R&D
Entera & Amgen Sign Research Agreement
Entera will use its proprietary drug delivery platform to develop oral formulations for one preclinical large molecule program that Amgen has selected.12.11.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
InveniAI, Kyowa Hakko Kirin Partner for Drug Discovery
Together using artificial intelligence and machine learning, will leverage InveniAI's AlphaMeld platform for further discovery12.11.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Biogen Licenses ALS Treatment from Ionis
Obtained worldwide, exclusive, royalty-bearing license to develop and commercialize BIIB067 (IONIS-SOD1RX)12.06.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
VBI, Brii Bio Partner for Hepatitis B
Brii Bio paid VBI $11 million upfront, including a $4 million upfront payment & a $7 million equity investment at $3 a share12.06.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Icagen & Roche Partner for Neurological Therapy
Will develop and commercialize small molecule ion channel modulators for the treatment of neurological disorders12.05.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
Evotec & LEO Pharma Partner for Drug Discovery
To generate new leads against innovative targets for a range of dermatological conditions12.04.18
-
Bio News | Biologics, Proteins, Vaccines | Drug Development | Facilities | Industry News | R&D
GE Launches Biotechnology Mfg. Center
To produce a purification platform for efficiency in purification of mfg. biopharmaceuticals, gene therapies & viral vectorsVideos
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
TRACON & I-Mab Partner for Immuno-Oncology
TRACON to be responsible for the regulatory & clinical development of I-Mab's TJD5 & up to five of the BsAbs in North America11.29.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
WuXi Biologics, ABL Bio Enter Development Deal
For up to 8 antibody therapeutics including ABL Bio’s biologics pipelines & collaboration programs between ABL Bio and I-Mab11.28.18
-
Bio News | Drug Development | Drug Discovery | Industry News | R&D | Reader Showcase
Aji Bio-Pharma Introduces New ADC Mfg. Technology
AJICAP technology lets developers of ADCs to better control the location of payload conjugation to an antibody11.28.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | Laboratory Testing | R&D
Precision, MaxCyte Enter Clinical Agreement
Allows Precision to use MaxCyte's Flow Electroporation® technologies to robustly deliver ARCUS genome-editing technology11.15.18
-
Bio News | Collaborations & Alliances | Industry News | Laboratory Testing | R&D
Quanticate Links Up with Lancaster University
Quanticate to research optimizing clinical trial design for rare disease and the role of response-adaptive randomisation11.15.18
-
Breaking News | Collaborations & Alliances | R&D
BridgeBio Pharma Enters Genetic Disease Alliance
Research collaboration aims to identify and develop genetic disease therapies11.12.18
